INTRODUCTION

Epidermolytic hyperkeratosis (EHK) was first introduced in 1966
1 & found in a number of congenital & aquired skin disorders. Epidermolytic hyperkeratosis (EHK), also known as bullous congenital ichthyosiform erythroderma, is an autosomal dominant trait with a prevalence of approximately 1 in 200,000 to 300,000 persons. 2 The disease is named for the distinctive histopathologic feature of vacuolar degeneration and associated hyperkeratosis of the epidermis. It usually presents at birth with blistering and redness.
CASE REPORT
A 6month old female child came to our OPD with hyperkeratosis all over the body, mostly over the anterior side of the neck, all flexors, in fragluteal fold, abdominal wall since birth (Figure 1 ). Palm, sole & face is spared. Nails are also not involved. She did not have any neurological abnormality & has a normal height as per his age. She has a history of superficial erosion at the sites of minor trauma after birth and bullous lesions over 
DISCUSSION
Epidermolytic hyperkeratosis is an autosomal dominant disorder of keratinization. The disease is named for the distinctive histopathological features of vacuolar degeneration of the epidermis (i.e. epidermolysis) and associated hyperkeratosis. There is a high frequency of spontaneous mutations and as many as half the cases have no family history and they represent new mutational events. 3 The disease usually presents at birth with blistering, redness and peeling. With time, generalized hyperkeratosis may develop, which may or may not be associated with erythroderma. An underlying genetic defect of keratin synthesis or degradation involving keratin 1 and/or keratin 10 has been suggested. 4 Interestingly keratin 1 mutation is associated with severe palmoplantar hyperkeratosis while keratin 10 mutations are not. 5 Family studies have confirmed an autosomal dominant inheritance and linked it to keratin gene clusters on chromosome 12q and 17q [6] [7] [8] Six clinical phenotypes of EHK have been distinguished depending on the presence of severe palmar/plantar hyperkeratosis: three subgroups with palm/sole (PS type) hyperkeratosis and the other three subgroups with no palm/sole (NPS type) hyperkeratosis. At birth the infant may show marked hyperkeratosis, erythroderma or even present as a collodion baby. The scales are soon lost, leaving a generalized moist, tender erythroderma followed by development of widespread blistering which heals without scarring. As the patient becomes older, erythema and blistering becomes less apparent and later the disease is complicated by the development of verrucous hyperkeratosis, especially in the flexures. Nail dystrophy may be a feature. Some cases are complicated by sepsis, fluid loss and electrolyte imbalance. 9 Severely affected children may be of short stature, although many catch up in adolescence. The condition is associated with markedly increased epidermopoiesis. 10 The histopathological features known as epidermolytic hyperkeratosis (EH) are very striking.
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Most characteristically it is associated with, (1) massive hyperkeratosis, papillomatosis and acanthosis, (2) greatly thickened and abnormal granular cell layer, (3) intensely eosinophilic intracytoplasmic inclusions in granular layer, (4) intragranular split due to extreme intracellular edema (cytolysis) and (5) intraepidermal blister formation (following cytolysis).
The patients are managed conservatively with the use of topical emollients, appropriate antibiotics and antiseptic creams when required, topical calcipotriol helps in some cases but may induce irritation. Oral retinoids may be required in severe cases. It reduces scaling but may induce skin fragility and blistering. 12 A mildly affected parent may have severely affected child or patient may develop lesion without family history due to de novo mutation. In case of positive family history, prenatal diagnosis can be done with foetal skin at 20 weeks of gestation with ultrasound guided foetoscopy or earlier by direct DNA sequencing chorionic villous sampling. Treatment is mainly symptomatic. Ammonium lactate 12% lotion reduced hyperkeratosis to some extent. Regular wash with antiseptic cleansing lotion is advised. It has been noted that patient with k10 mutation without palmoplantar hyperkeratosis response better with retinoid therapy, so presently retinoid therapy being considered
